Drug Discovery World

JULY 20, 2023

As new drug discovery developments, such as AI-powered approaches, advance, we anticipate the demand for comprehensive, commercial compound-screening solutions, such as SMM, to grow rapidly, and Arrayjet is well-positioned to provide these to researchers.”

Small Molecule 100

Small Molecule Compound Screening Assay Development RNA 100

Sygnature Discovery

JANUARY 17, 2023

Sygnature Discovery (“Sygnature”) is delighted to announce the acquisition of SB Drug Discovery, a world leading provider of ion channel and receptor drug discovery research delivering cell line generation and compound screening solutions in neuroscience and other therapeutic indications. SB is based in Glasgow and employs 55 people.

Compound Screening 52

Compound Screening Marketing Assay Development Drugs 52

The ChEMBL-og

APRIL 16, 2024

New Deposited Datasets CHEMBL5291702 - European Medicines Agency CHEMBL5303304 - EUbOPEN Chemogenomics Library - IncuCyte (assays link to document CHEMBL4689842) CHEMBL5303761 - Data for DCP probe BI-3231 CHEMBL5303762 - Data for DCP probe BI-8668 CHEMBL5303763 - Data for DCP probe BI-3802 CHEMBL5303764 - Data for DCP probe BI-3812 CHEMBL5303765 - (..)

Clinical Trials 110

Clinical Trials FDA Cell Based Assays Packaging 110

The Pharma Data

JANUARY 6, 2021

The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab. Next-generation digital technologies are having an immense impact on the drug discovery process.

Cell Based Assays 52

Cell Based Assays Compound Screening Organic Chemistry DNA 52

Drug Discovery World

OCTOBER 4, 2022

Using its proprietary compound screening platform, Oligomerix discovers and develops differentiated, oral, small molecule inhibitors of tau self-association that are easy to administer and cost-effective. .

Disease 130

Disease Small Molecule Compound Screening Clinical Development 130

Drug Target Review

NOVEMBER 1, 2023

We need to build the assays that we need for compound screening. Can you elaborate on how these techniques are integrated into your research process and how they contribute to advancing cancer drug discovery? We are involved from a very early stage once a target is validated.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

Drug Discovery World

JANUARY 23, 2023

They cannot be easily scaled or broadly applied to other therapeutic programs or disease areas, and the data generated from any compound screens will be narrowly focused on the target hypothesis. These steps are time-consuming and specific to answering a particular scientific question at hand.

Clinical Trials 147

Clinical Trials Compound Screening Drugs Trials 147